Trial Profile
Efficacy of simeprevir, pegylated-interferon and ribavirin therapy in patients with hepatitis C genotype 1
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 22 Dec 2015 New trial record